United Therapeutics Corporation (UTHR) — Stock Score Summary

United Therapeutics Corporation (UTHR) has a MoatMap StockRank of 90/100 based on Quality (77/100), Value (35/100), and Momentum (65/100) factor scores. The current signal is STRONG BUY. United Therapeutics is a high-quality biotech firm with strong financials, but its core focus on pulmonary arterial hypertension and organ manufacturing does not align with our active 18-month macro themes.

United Therapeutics Corporation is a biotechnology company dedicated to developing and commercializing innovative therapies for patients with rare and life-threatening diseases, predominantly pulmonary arterial hypertension (PAH) and other cardiopulmonary conditions. The company holds a strong market position through its proprietary drug portfolio and orphan drug designations, addressing significant unmet medical needs in specialized therapeutic areas.

Key Financial Metrics

Price$540.05
Market Cap$23.9B
P/E (TTM)21.40
P/E (Forward)18.20
Price/Book4.13
Return on Equity20.3%
Return on Invested Capital23.7%
Gross Margin86.6%
Operating Margin41.7%
Revenue Growth-1.6%
Free Cash Flow$566M

United Therapeutics Corporation operates in the Drug Manufacturers - Specialty & Generic industry, part of the Healthcare sector (United States).

Frequently Asked Questions

What is United Therapeutics Corporation’s (UTHR) StockRank?
MoatMap’s StockRank for United Therapeutics Corporation (UTHR) is 90/100, with a Strong Buy signal. It is a composite of Quality (77), Value (35), and Momentum (65) factor ranks across MoatMap’s 19,000+ stock universe.
Does United Therapeutics Corporation have an economic moat?
United Therapeutics Corporation (UTHR) has a Quality factor score of 77/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage — the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the characteristics of a moated business.
Is United Therapeutics Corporation a buy, hold, or sell?
MoatMap’s current signal for United Therapeutics Corporation (UTHR) is Strong Buy, based on a StockRank of 90/100. Signals are derived mechanically from the StockRank composite and should be one input among many — combine with your own thesis on management, competitive position, and valuation.
What sector is United Therapeutics Corporation in?
United Therapeutics Corporation (UTHR) operates in the Healthcare sector, specifically the Drug Manufacturers - Specialty & Generic industry (United States).
Browse all ranked stocksUTHR deep dive reportAI ChampionsHow we score stocksSense-check another stock